论文信息 - P0641 : Excellent 5-year survival in caucasian chronic hepatitis B (CHB) patients with or without cirrhosis under long-term entecavir (ETV) or tenofovir (TDF) therapy and the impact of hepatocellular carcinoma (HCC) - 字舞流文

P0641 : Excellent 5-year survival in caucasian chronic hepatitis B (CHB) patients with or without cirrhosis under long-term entecavir (ETV) or tenofovir (TDF) therapy and the impact of hepatocellular carcinoma (HCC)

M. Buti | R. Idilman | C. Yurdaydın | P. Lampertico | H. Janssen | J. Calleja | R. Esteban | B. Hansen | V. Sypsa | S. Savvidou | S. Manolakopoulos | G. Dalekos | H. Chi | N. Gatselis | I. Vlachogiannakos | J. Goulis | M. Colombo | J. Revilla | G. Mangia | O. Keskin | G. Papatheodoridis | Kostas Galanis | Vana Sypsa | Ioannis Vlachogiannakos